XML 19 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Net Income (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted

 
Three months ended March 31,
Three months ended March 31,
 
2020
 
2019
 
Class A
 
Class B
 
Class A
 
Class B
 
 
 
 
 
 
 
 
Basic net income (loss) per share:
 
 
 
 
 
 
 
Numerator
 
 
 
 
 
 
 
Net income (loss) attributable to common stockholders
$
24.5

 
$
14.8

 
$
(4.0
)
 
$
(3.7
)
Denominator
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding used in computing basic net income (loss) per share
260.0

 
157.3

 
215.1

 
195.4

Net income (loss) per common share, basic
$
0.09

 
$
0.09

 
$
(0.02
)
 
$
(0.02
)
Diluted net income (loss) per share:
 
 
 
 
 
 
 
Numerator
 
 
 
 
 
 
 
Net income (loss) attributable to common shareholders
$
24.5

 
$
14.8

 
$
(4.0
)
 
$
(3.7
)
Reallocation of net income as a result of conversion of Class B to Class A common stock
$
14.8

 

 

 

Net income (loss) attributable to common stockholders for diluted EPS
$
39.3

 
$
14.8

 
$
(4.0
)
 
$
(3.7
)
Denominator
 
 
 
 
 
 
 
Weighted-average number of common shares outstanding used in computing diluted net income (loss) per share
260.0

 
157.3

 
215.1

 
195.4

Weighted-average effect of dilutive RSUs and employee stock options
1.6

 
0.4

 

 

Conversion of Class B to Class A common stock
157.3

 

 

 

Weighted-average number of common shares outstanding used in computed diluted net income (loss) per share
418.9

 
157.7

 
215.1

 
195.4

Net income (loss) per common share, diluted
$
0.09

 
$
0.09

 
$
(0.02
)
 
$
(0.02
)

Schedule of potentially dilutive securities excluded from computation of earnings per share
The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive was as follows:
 
Three months ended
March 31,
 
 
2020
 
2019
 
 
 
 
 
 
Restricted stock units
15.2

 
24.6

 
Restricted stock awards
0.2

 

 
Options to purchase shares of common stock
1.3

 
1.8

 
Co-Founder Grants
14.2

 
14.7

 
Total
30.9

 
41.1